Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Date & Meeting Presentation pdf file

December 2004
Division of Public Health and Primary Care, Research Seminar Series

Evaluation of public health programmes: the example of early childhood interventions.
Stavros Petrou
Not available

November 2004, Department of Psychiatry

How to integrate health economics into clinical guidelines? The mental health guidelines experience.
Simon J

Not available

October 2004, International Society for Pharmacoeconomics and Outcomes Research (ISPOR): 7th European Congress, Hamburg

Parametric survival models and decision models: Relating continuous hazards to discrete-time transition probabilities.
Briggs A

Link to file

October 2004, 26th Annual Meeting of the Society for Medical Decision Making (SMDM), Atlanta

Probabilistic Sensitivity Analysis: Is it useful and should it be mandatory?
Weinstein M, Claxton K, Sculpher M, Paltiel AD, Briggs A, Hunink M, Fryback D

Link to file

September 2004
5th European Conference on Health Economics, London

Analysis of the frequency and impact of adverse health care events using data from a large population survey.
Gray A, Fenn P, Rickman N

Link to file

September 2004
5th European Conference on Health Economics, London

The cost-effectiveness of genetic testing for sudden cardiac death.
Wordsworth S, Leal J, Legood R, de Coulon R.

Not available

September 2004
5th European Conference on Health Economics, London

Economic evaluation of antidepressant therapy, cognitive behaviour therapy and their combination for the treatment of depression in the UK.
Simon J

Not available

September 2004
5th European Conference on Health Economics, London

Economic evaluation of simvastatin in people at different vascular disease risk based on a large randomised trial.
Mihaylova B, Armitage J, Briggs A, Collins R, Gray A, Parish S and Young A on behalf of the Heart Protection Study Collaborative Group

Not available

September 2004
5th European Conference on Health Economics, London

Using discrete choice experiments within a CBA framework: Some considerations.
McIntosh E, Ryan M, Sculpher M and Vale L

Not available

September 2004
5th European Conference on Health Economics, London

Testing the transferability of discrete choice experiment results in the modernisation of out-of-hours health services: a within-country study.
Gerard K

Not available

September 2004
5th European Conference on Health Economics, London

Analysis of the frequency and impact of adverse health care events using data from a large population survey.
Gray AM , Fenn P, Rickman N

Not available

August 2004
Joint Statistical Meetings (JSM), Toronto

The future for statistical analysis of net-benefit in cost-effectiveness analysis.
Briggs A

Link to file

July 2004
British Congress of Obstetrics and Gynaecology, Glasgow

Economic evaluation of the Magpie Trial.
Simon J, Gray AM, Duly L on behalf of the Magpie Trial Collaborating Group.

Not available

June 2004
Health Economists Study Group (HESG), Glasgow

A cost benefit analysis of management alternatives for first trimester miscarriage: Results from a discrete choice experiment within a radomised controlled trial.
McIntosh E, Petrou S

Not available

June 2004
Health Economists Study Group (HESG), Glasgow

Parametric survival models and decision models: relating continuous hazards to discrete-time transition probabilities.
Briggs A, Campbell H, Clarke P, Sculpher M

Link to file

June 2004
The Canadian Association for Population Therapeutics (CAPT) Annual Conference, Winnipeg

In search not of power, but of significance: A tribute to Bernie O'Brien
Briggs A

Not available

June 2004
Health Economic Facility, Birmingham

Using discrete choice experiments to elicit preferences for attributes of hernia repair: An exploration of the strength of preference modelling approach
McIntosh E

Link to file

May 2004
The Spanish Health Economics Association Meeting, Madrid


Estimating the association
between SF-36 responses and EQ-5D utility values by direct mapping (out of sample prediction)
Rivero-Arias O
Link to file

May 2004
10as Jornadas de Ciências Farmacêuticas, Monte de Caparica, Portugal


Contribution of Health Economics to resource allocation
Leal J
Link to file

May 2004
ISPOR 9th Annual International Meeting, Arlington


Design of economic evaluations alongside clinical trials. Report
of the Task Force on Economic appraisal Alongside Clinical trials
Briggs A
Not available
May 2004
Statisticians in the Pharmaceutical Industry Annual Conference, Wrexham

What is it that NICE want? Revised guidance.
Briggs A
Link to file
May 2004
Workshop on Health Economics and Epidemiology, Basel

Net benefits approach to cost-effectiveness: advantages and possible extensions
Briggs A
Link to file
April 2004
NHS Health Economics Support Group,
University of East Anglia

Assessing the cost-effectiveness of new technologies to screen for cervical cancer: some national and international experience
Legood R
Not available
January 2004
Beds and Herts' Primary Care Network Annual Cardiac Conference

Cost-effectiveness of Primary Prevention: The use of risk models and an illustration based on the PolypillC.
Briggs A
Link to file
January 2004
HESG, Paris

Estimating the association between SF-36 responses and EQ-5D utility values by direct mapping
Gray AM, Clarke P, Rivero-Arias O
Not available
January 2004
HESG, Paris

Can we do better than average? An empirical application of centre specific versus averaged unit costing
Wordsworth S, Wolstenholme J
Link to file
January 2004
OCD Guideline Development Group (NCCMH, London)
Introduction to Health Economics
Simon J
Not available